Stop using these cough syrups immediately, warns Telangana Drug Authority

Written By :  Ruchika Sharma
Published On 2025-10-09 07:30 GMT   |   Update On 2025-10-09 07:30 GMT
Advertisement

Telangana: The Drugs Control Administration, Telangana, has issued an urgent public alert advising citizens to immediately stop using two cough syrups found adulterated with Diethylene Glycol (DEG)—a highly toxic subtance.

The alert follows a report from the Drug Testing Laboratory, Government of Madhya Pradesh, Bhopal, which detected the presence of DEG in the following syrups:

1. “Relife” Cough Syrup (Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate & Menthol Syrup)

Advertisement

o Batch No.: LSL25160

o Expiry Date: 12/2026

o Manufactured By: M/s. Shape Pharma Pvt. Ltd., Plot No. 4, Shekhpar – 363510, Gujarat

2. “Respifresh TR” Cough Syrup (Bromhexine Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup)

o Batch No.: R01GL2523

o Expiry Date: 12/2026

o Manufactured By: M/s. Rednex Pharmaceuticals Pvt. Ltd., Survey No. 586 & 231, Near SKF Bearing, Bavla–Bagodara N.H. 8A, Taluka Bavla, District Ahmedabad, Gujarat – 383220

Read also: MP Cough Syrup Case: Doctors' associations demand central probe, case withdrawal for arrested paediatrician

The DCA has directed all Drugs Inspectors and Assistant Directors across Telangana to immediately alert retailers, distributors, and hospitals to freeze stocks of the said product batches and ensure that the same are not dispensed or sold under any circumstances.

Citizens in possession of these products have been urged to report them to the nearest Drugs Control Authority without delay or report possession of the said products directly to the Drugs Control Administration, Telangana.

Read also: Cough syrup crisis: Tamil Nadu suspends 2 drug inspectors, moves to close pharma co

"The Drugs Control Administration, Telangana, has initiated necessary enforcement measures and is actively monitoring the situation to prevent further risk to public health. The public is urged to exercise utmost caution and refrain from using the aforementioned products to avert any potential health hazards associated with Diethylene Glycol toxicity," the administration stated.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News